| | Title | Authors / Editors | Date |
|
unige:160866 |
HCV disease burden and population segments in Switzerland |
Bihl, Florian; Bruggmann, Philip; Castro Batänjer, Erika; Dufour, Jean-Francois; ... Blach, Sarah |
2022 |
|
unige:155414 |
Mir-21 Suppression Promotes Mouse Hepatocarcinogenesis |
Correia De Sousa, Marta; Calo, Nicolas Virgile; Sobolewski, Cyril; Gjorgjieva, Monika; ... Foti, Michelangelo |
2021 |
|
unige:151957 |
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland |
Müllhaupt, Beat; Semela, David; Ruckstuhl, Lisa; Magenta, Lorenzo; ... Semmo, Nasser |
2021 |
|
unige:151338 |
Hepatitis C prevalence in the psychiatric setting: cost-effectiveness of scaling-up screening and direct-acting antiviral therapy |
Girardin, François; Painter, Chris; Hearmon, Natalie; Eddowes, Lucy; ... Vernaz-Hegi, Nathalie |
2021 |
|
unige:156710 |
Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysis |
Sadeghimehr, Maryam; Bertisch, Barbara; Negro, Francesco; Butsashvili, Maia; ... Estill, Janne Anton Markus |
2021 |
|
unige:152346 |
HDV pathogenesis: unravelling ariadne's thread |
Tseligka, Eirini; Clément Leboube, Sophie; Negro, Francesco |
2021 |
|
unige:152654 |
Residual risk of liver disease after hepatitis C virus eradication |
Negro, Francesco |
2021 |
|
unige:152659 |
NAFLD and MAFLD as emerging causes of HCC: a populational study |
Myers, Shuna; Neyroud, Isabelle; Spahr, Laurent François Joséph; Gkouvatsos, Konstantinos; ... Goossens, Nicolas |
2021 |
|
unige:152660 |
Real-world outcomes in historically underserved patients with chronic hepatitis C infection treated with Glecaprevir/Pibrentasvir |
Aghemo, Alessio; Horsmans, Yves; Bourgeois, Stefan; Bondin, Mark; ... Lampertico, Pietro |
2021 |
|
unige:152661 |
The changing context of hepatitis D. |
Rizzetto, Mario; Hamid, Saeed; Negro, Francesco |
2021 |
|
unige:152664 |
Recommandations pour le suivi des patients atteints d'hépatite C guérie |
Bobzin, Carina; Bsiger, Christophe; Bruggmann, Philip; Cerny, Andreas; ... Thurnheer, Maria Christine |
2021 |
|
unige:152677 |
MAFLD considerations as a part of the global hepatitis C elimination effort: an international perspective |
Fouad, Yasser; Lazarus, Jeffrey V; Negro, Francesco; Peck-Radosavljevic, Markus; ... Colombo, Massimo |
2021 |
|
unige:152678 |
Maladies infectieuses |
Nguyen, Aude; Posfay Barbe, Klara; Blanchard Rohner, Géraldine; Buvelot, Hélène; ... Csaki Huttner, Angela |
2021 |
|
unige:160629 |
Endpoints and New Options for Treatment of Chronic Hepatitis D |
Lok, Anna S; Negro, Francesco; Asselah, Tarik; Farci, Patrizia; Rizzetto, Mario |
2021 |
|
unige:160865 |
Hepatitis C virus: current steps toward elimination in Germany and barriers to reaching the 2030 goal |
Sarrazin, Christoph; Boesecke, Christoph; Golsabahi-Broclawski, Solmaz; Moog, Gero; ... Wörns, Marcus-Alexander |
2021 |
|
unige:161318 |
The never-ending debate about conflict of interests' |
Negro, Francesco |
2021 |
|
unige:148292 |
Is antibody-dependent enhancement playing a role in COVID-19 pathogenesis? |
Negro, Francesco |
2020 |
|
unige:148294 |
Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies |
Alfaiate, Dulce; Clement, Sophie; Rocha Gomes, Diana Bianca; Goossens, Nicolas; Negro, Francesco |
2020 |
|
unige:148296 |
Reply to: "Cirrhotic controls in a pooled analysis of hepatitis D and hepatocellular carcinoma" |
Alfaiate, Dulce; Clement, Sophie; Goossens, Nicolas; Negro, Francesco |
2020 |
|
unige:148309 |
The MD-PhD program in Geneva: a 10-year analysis of graduate demographics and outcomes |
Dos Santos Rocha, André Alexandre; Combescure, Christophe; Negro, Francesco |
2020 |
Negro, Francesco
add all
remove all
